MPPE1 and neoplasm: For head and neck squamous cell carcinoma (HNSC) and lung adenocarcinoma (LUAD), a higher expression of the cDC1 transcriptomic signature in tumor was also associated to a better clinical outcome by at least two independent studies (55, 62, 80).